We have preliminary data showing that in ovarian cancer patient xenografts made resistant in vivo to cisplatin, a higher level of ERCC1/XPF complex detected by PLA was found compared to platinum-sensitive xenografts [97]. The gene discussed is ERCC1; the disease is ovarian carcinoma.